Skip to main content
. 2022 Jun 20;11(6):826. doi: 10.3390/antibiotics11060826
3GC Third-generation cephalosporin
AC Antimicrobial consumption
AMR Antimicrobial resistance
AS Antimicrobial stewardship
BSI Bloodstream infection
CAESAR Central Asian and European Surveillance of Antimicrobial Resistance
CDI Clostridioides difficile infection
Cef R Third-generation cephalosporin-resistant
Cef S Third-generation cephalosporin-susceptible
CL Change in level
COVID-19 Coronavirus disease 2019
CR Carbapenem-resistant
CRAB Carbapenem-resistant Acinetobacter baumanii
CR-GNB Carbapenem-resistant Gram-negative bacteria
CRO Carbapenem-resistant organism
CS Carbapenem-susceptible
CT Change in trend
DDD Defined daily dose
EARS-Net European Antimicrobial Resistance Surveillance Network
HAI Healthcare-associated infection
ICU Intensive care unit
ID Incidence density
IPC Infection prevention and control
MDROs Multidrug-resistant organisms
MRSA Methicillin-resistant Staphylococcus aureus
MSSA Methicillin-susceptible Staphylococcus aureus
PAF Prospective audit and feedback
PD Patient-days
PPE Personal protective equipment
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
VAP Ventilator-associated pneumonia
VR Vancomycin-resistant
VS Vancomycin-susceptible